Encephalopathies: The emerging diabetic complications

Acta Diabetologica

Volumn 47, Issue 4, 2010, Pages 279-293

  Sima, Anders A F ^a  

^a NONE

Author keywords

Alzheimer's disease; Encephalopathy; Insulin deficiency; Insulin resistance; Type 1 diabetes; Type 2 diabetes

Indexed keywords

AMYLOID BETA PROTEIN; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HORMONE RECEPTOR STIMULATING AGENT; INSULIN; LEVACECARNINE; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; TAU PROTEIN; UNCLASSIFIED DRUG;

ACADEMIC FAILURE; AGE DISTRIBUTION; AGING; ALZHEIMER DISEASE; APOPTOSIS; BRAIN DISEASE; BRAIN INFARCTION; CLINICAL TRIAL; DIABETIC ENCEPHALOPATHY; DIABETIC NEUROPATHY; DRUG MECHANISM; HIGH RISK POPULATION; HORMONE ACTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; INSULIN RESISTANCE; INTELLIGENCE; LEARNING DISORDER; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RECALL; REVIEW; SIGNAL TRANSDUCTION;

AMYLOID; ANIMALS; BRAIN DISEASES, METABOLIC; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; MODELS, BIOLOGICAL; TAU PROTEINS;

EID: 78549234002     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0218-0     Document Type: Review

References (138)

1. Biessels GJ, Luchsinger JA (eds) (2009) Diabetes and the brain. Humana Press, New York
2. WR Miles HF Root 1922 Psychologic tests applied in diabetic patients Arch Intern Med 30 767 777
3. A Ott RP Stolk F van Harskamp HA Pols A Hofman MM Breteler 1999 Diabetes mellitus and the risk of dementia: The Rotterdam Study Neurology 58 1937 1941
4. Z Arvanitakis RS Wilson JL Bienias DA Evans DA Bennett 2004 Diabetes mellitus and risk of Alzheimer's disease and decline in cognitive function Arch Neurol 61 661 666 15148141
5. WL Xu CX Qui A Wahlin B Winblad L Fratiglioni 2004 Diabetes mellitus and risk of dementia in the Kungshohman project: a 6 year follow-up Neurology 63 1181 1186 1:STN:280:DC%2BD2crgvVWhuw%3D%3D 15477535
6. M Kumari M Marmot 2005 Diabetes and cognitive function in a middle-aged cohort: findings from the Whitehall II study Neurology 65 1597 1603 16301488 (Pubitemid 41689475)
7. G Worrall E Moulton E Briffett 1993 Effect of type II diabetes mellitus on cognitive function J Fam Pract 36 639 643 1:STN:280:DyaK3s3otVGmtg%3D%3D 8505607
8. A Fontbonne C Berr P Ducimetière A Alpérovitch 2001 Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study Diabetes Care 24 366 370 1:STN:280:DC%2BD3M7otVShsw%3D%3D 11213894
9. HT Nguyen SA Black LA Roy DV Espino KS Markides 2002 Predictors of decline in MMSE scores among older Mexican Americans J Gerontol A Biol Sci Med Sci 57 M181 M185 11867656
10. B van Harten J Oosterman D Muslimovic BJ van Loon P Scheltens HC Weinstein 2007 Cognitive impairment of MRI correlates in the elderly patients with type 2 diabetes mellitus Age Ageing 36 164 170 17350976 (Pubitemid 46455395)
11. LA Hiltunen SM Keinänen-Kiukaanniemi EM Läärä 2001 Glucose tolerance and cognitive impairment in an elderly population Public Health 115 197 200 1:STN:280:DC%2BD3MzntFGjuw%3D%3D 11429715
12. JH Wu MN Haan J Liang D Ghosh HM Gonzalez WH Herman 2003 Impact of diabetes on cognitive function among older Latinos: a population-based cohort study J Clin Epidemiol 56 686 693 12921938
13. LB Hassing MD Grant SM Hofer NL Pedersen SE Nilsson S Berg G McClearn B Johansson 2004 Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study J Int Neuropsychol Soc 10 599 607 15327738 (Pubitemid 39077200)
14. CM Ryan MO Geckle 2000 Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes Diabetes Care 23 1486 1493 1:STN:280: DC%2BD3cvmvVaqsw%3D%3D 11023141
15. AM Abbatecola G Paolisso M Lamponi S Bandinelli F Lauretani L Launer L Ferrucci 2004 Insulin resistance and executive dysfunction in older persons J Am Geriatr Soc 52 1713 1718 15450050
16. MG Dik C Jonker HC Comijs DJ Deeg A Kok K Yaffe BW Penninx 2007 Contributions of metabolic syndrome components to cognition in older individuals Diabetes Care 30 2655 2660 17563341
17. P Komulainen TA Lakka M Kivipelto M Hassinen EL Helkala I Haapala A Nissinen R Rauramaa 2007 Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women Dement Geriatr Cogn Disord 23 29 34 17068394 (Pubitemid 46005788)
18. A Convit OT Wolf C Tarshish MJ de Leon 2003 Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly Proc Natl Acad Sci USA 100 2019 2022 1:CAS:528:DC%2BD3sXhsFGrsb8%3D 12571363
19. JB Pinkston N Alekseeva E González Toledo 2009 Stroke and dementia Neurol Res 31 824 831 19723451
20. EJ Schoenle D Schoenle L Molinari RH Largo 2002 Impaired intellectual development in children with Type I diabetes: association with HbA(1c), age at diagnosis and sex Diabetologia 45 108 114 1:CAS:528:DC%2BD38Xitl2js7s%3D 11845229
21. J Dobbing J Sands 1971 Vulnerability of developing brain. IX. The effect of nutritional growth retardation on the timing of the brain growth-spurt Biol Neonate 19 363 378 1:STN:280:DyaE387ptFahtw%3D%3D 5149290
22. L Kramer P Fasching C Madl B Schneider P Damjancic W Waldhäusl K Irsigler G Grimm 1998 Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment Diabetes 47 1909 1914 1:CAS:528:DyaK1cXnvVCru78%3D 9836523
23. The Diabetes Control Complications Trial/Epidemiology of Diabetes Interventions, Complications (DCCT/EDIC) Study Research Group 2007 Long-term effect of diabetes and its treatment on cognitive function N Engl J Med 356 1842 1852
24. AAF Sima W Zhang O Muzik CW Kreipke JA Rafols WH Hoffman 2009 Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-peptide Rev Diabet Stud 6 211 222 20039010
25. T Brismar L Hyllienmark K Ekberg BL Johansson 2002 Loss of temporal lobe beta power in young adults with type 1 diabetes mellitus Neuroreport 13 2469 2473 12499851
26. T Erkinjuntti S Ganthier 2009 The concept of vascular cognitive impairment Front Neurol Neurosci 24 79 85 19182465
27. JA Luchsinger MX Tang Y Stern S Shea R Mayeux 2001 Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort Am J Epidemiol 154 635 641 1:STN:280:DC%2BD3MrjvVKnsA%3D%3D 11581097
28. R Peila BL Rodriguez LJ Launer Honolulu-Asia Aging Study 2002 Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies Diabetes 51 1256 1262 1:CAS:528:DC%2BD38Xis1Ois7Y%3D 11916953
29. R Peila BL Rodriguez LR White LJ Launer 2004 Fasting insulin and incident dementia in an elderly population of Japanese-American men Neurology 63 228 233 1:CAS:528:DC%2BD2cXlsV2jt74%3D 15277613
30. A Akomolafe A Beiser JB Meigs R Au RC Green LA Farrer PA Wolf S Seshadri 2006 Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study Arch Neurol 63 1551 1555 17101823
31. WL Xu E von Strauss CX Qiu B Winblad L Fratiglioni 2009 Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study Diabetologia 52 1031 1039 1:CAS:528:DC%2BD1MXlt1Gqtbo%3D 19280172
32. M Kivipelto T Ngandu L Fratiglioni M Viitanen I Kåreholt B Winblad EL Helkala J Tuomilehto H Soininen A Nissinen 2005 Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease Arch Neurol 62 1556 1560 16216938 (Pubitemid 41434560)
33. RA Whitmer DR Gustafson E Barrett-Connor MN Haan EP Gunderson K Yaffe 2008 Central obesity and increased risk of dementia more than 3 decades later Neurology 71 14 1057 1064 1:STN:280:DC%2BD1cnjtFGrsw%3D%3D 18367704
34. JD Spence 1996 Cerebral consequences of hypertension: where do they lead? J Hypertens Suppl 14 S139 S145 1:STN:280:DyaK2s7nslehtw%3D%3D 9120671
35. T Etgen D Sauder H Bichel K Sauder H Förstl 2010 Cognitive decline: the relevance of diabetes, hyperlipidaemia and hypertension Br J Diab Vasc Dis 10 115 10.1177/1474651410368408
36. F Forette ML Seux JA Staessen L Thijs MR Babarskiene S Babeanu A Bossini R Fagard B Gil-Extremera T Laks Z Kobalava C Sarti J Tuomilehto H Vanhanen J Webster Y Yodfat WH Birkenhager Systolic Hypertension in Europe Investigators 2002 The prevention of dementia with anti-hypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) Study Arch Int Med 162 2046 2052
37. N-C Li A Lee RA Whitmer M Kivipelto E Lowler LE Kazis B Wolozin 2010 Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: a prospective cohort analysis BMJ 340 b5465 10:1136/baijb5465 20068258
38. N Tezapsidis JM Johnston MA Smith JW Ashford G Casadesus NK Robakis B Wolozin G Perry X Zu SJ Greco S Sarkar 2009 Leptin: a novel therapeutic strategy for Alzheimer's disease J Alzheimer Dis 16 731 740
39. F Nourhashémi V Deschamps S Larrieu L Letenneur JF Dartigues P Barberger-Gateau PAQU ID Study. Personnes Agées Quid 2003 Body mass index and incidence of dementia: the PAQUID study Neurology 60 117 119 12525731
40. VW Henderson JR Guthrie L Dennerstein 2003 Serum lipids and memory in a population based cohort of middle age women J Neurol Neurosurg Psychiatry 74 1530 1535 1:STN:280:DC%2BD3srksVKiuw%3D%3D 14617710
41. SE Vermeer PJ Koudstaal M Oudkerk A Hofman MM Breteler 2002 Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study Stroke 33 21 25 11779883
42. FE de Leeuw JC de Groot E Achten M Oudkerk LM Ramos R Heijboer A Hofman J Jolles J van Gijn MM Breteler 2001 Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study J Neurol Neurosurg Psychiatry 70 9 14 11118240
43. RI Scahill C Frost R Jenkins JL Whitwell MN Rossor NC Fox 2003 A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging Arch Neurol 60 989 994 12873856
44. AA Gouw WM van der Flier F Fazekas EC van Straaten L Pantoni A Poggesi D Inzitari T Erkinjuntti LO Wahlund G Waldemar R Schmidt P Scheltens F Barkhof LADIS Study Group 2008 Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study Stroke 39 1414 1420 18323505
45. C Jongen J van der Grond LJ Kappelle GJ Biessels MA Viergever JP Pluim Utrecht Diabetic Encephalopathy Study Group 2007 Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus Diabet Med 24 166 171
46. B van Harten JM Oosterman BJ Potter van Loon P Scheltens HC Weinstein 2007 Brain lesions on MRI in elderly patients with type 2 diabetes mellitus Eur Neurol 57 70 74 17179707
47. T den Heijer SE Vermeer EJ van Dijk ND Prins PJ Koudstaal A Hofman MM Breteler 2003 Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI Diabetologia 46 1604 1610
48. ES Korf LR White P Scheltens LJ Launer 2006 Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study Diabetes Care 29 2268 2274 17003305
49. ES Korf EC van Straaten FE de Leeuw WM van der Flier F Barkhof L Pantoni AM Basile D Inzitari T Erkinjuntti LO Wahlund E Rostrup R Schmidt F Fazekas P Scheltens LADIS Study Group 2007 Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study Diabet Med 24 166 171 1:STN:280:DC%2BD2s%2FlsVejsQ%3D%3D 17257279
50. SM Manschot AM Brands J van der Grond RP Kessels A Algra LJ Kappelle GJ Biessels Utrecht Diabetic Encephalopathy Study Group 2006 Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes Diabetes 55 1106 1113 1:CAS:528:DC%2BD28XjsVGmtbg%3D 16567535
51. T Akisaki T Sakurai T Takata H Umegaki A Araki S Mizuno S Tanaka Y Ohashi A Iguchi K Yokono H Ito 2006 Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT) Diabetes Metab Res Rev 22 376 384 16506272
52. FE de Leeuw JC de Groot M Oudkerk JC Witteman A Hofman J van Gijn MM Breteler 2002 Hypertension and cerebral white matter lesions in a prospective cohort study Brain 125 765 772 11912110 (Pubitemid 34279772)
53. DS Knopman TH Mosley DJ Catellier AR Sharrett Atherosclerosis Risk in Communities (ARIC) Study 2005 Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort Neurology 65 876 881 16186527
54. Z-G Li W Zhang AAF Sima 2005 The role of impaired insulin/IGF action in primary diabetic encephalopathy Brain Res 1037 12 24 1:CAS:528: DC%2BD2MXitleqsb0%3D 15777748
55. SM de la Monte JR Wands 2008 Alzheimer's disease is type 3 diabetes-evidence reviewed J Diabet Sci Tech 2 1101 1113
56. SB Williams AB Goldfine FK Timimi HH Ting MA Roddy DC Simonson MA Creager 1998 Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo Circulation 97 1695 1701 1:CAS:528:DyaK1cXjsVSrsb8%3D 9591763
57. B Tesfomariam ML Brown RA Cohen 1991 Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C J Clin Invest 87 1643 1648
58. T Inoguchi P Li F Umeda HY Yu M Kakimoto M Imamura T Aoki T Etoh T Hashimoto M Naruse H Sano H Utsumi H Nawata 2000 High glucose level and free fatty acid stimulate reactive oxygen species production through protein-kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells Diabetes 49 1939 1945 1:CAS:528:DC%2BD3cXnvVOmtLo%3D 11078463
59. S Hoyer 2004 Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications Adv Exp Med Biol 541 135 152 1:CAS:528:DC%2BD2cXptFKhtrg%3D 14977212
60. S Hoyer 2004 Glucose metabolism and insulin receptor signal transduction in Alzheimer disease Eur J Pharmacol 490 115 125 1:CAS:528:DC%2BD2cXjt1Shsbs%3D 15094078
61. Z-G Li W Zhang AAF Sima 2007 Alzheimer-like changes in rat models of spontaneous diabetes Diabetes 56 1817 1824 1:CAS:528:DC%2BD2sXnvVWju70%3D 17456849
62. S Craft 2007 Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment Curr Alzheimer Res 4 147 152 1:CAS:528:DC%2BD2sXksVWkt70%3D 17430239
63. Z-G Li X Qiang AAF Sima 2001 Grunberger G: C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts Biochem Biophys Res Com 26 615 619
64. GJ Francis JA Martinez WQ Liu K Xu A Ayer J Fine UI Tuor G Glazner LR Hanson WH Frey 2nd C Toth 2008 Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy Brain 131 3311 3334 19015157
65. AAF Sima H Kamiya Z-G Li 2004 Insulin, C-peptide hyperglycemia and central nervous system complications in diabetes Eur J Pharmacol 490 187 197 1:CAS:528:DC%2BD2cXjt1Shtrw%3D 15094085
66. CR Pierson W Zhang Y Murakawa AAF Sima 2002 Early gene responses of trophic factors differ in nerve regeneration in type 1 and type 2 diabetic neuropathy J Neuropathol Exp Neurol 61 857 871 1:CAS:528:DC%2BD38XosFehs7o%3D 12387452
67. G Xu AAF Sima 2001 Altered immediate early gene expression is impaired in diabetic nerve: implications in regeneration J Neuropathol Exp Neurol 60 10 972 983 1:CAS:528:DC%2BD3MXns1yrsr8%3D 11589428
68. KK Yerneni W Bai BV Khan RM Medford R Natarajan 1999 Hyperglycemia- induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells Diabetes 48 855 864 1:CAS:528:DyaK1MXitFCqtLk%3D 10102704
69. P Luppi V Cifarelli H Tse J Piganelli M Trucco 2008 Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway Diabetologia 51 1534 1543 1:CAS:528:DC%2BD1cXovF2htbY%3D 18493738
70. AAF Sima W Zhang CW Kreipke JA Rafols WH Hoffman 2009 Inflammation in diabetic encephalopathy is prevented by C-peptide Rev Diabet Stud 6 37 42 19557294
71. Z-G Li W Zhang AAF Sima 2003 C-peptide enhances insulin-mediated cell growth and protection against high glucose induced apoptosis in SH-SY5Y cells Diabetes Metab Res Rev 19 375 385 12951645
72. MS Hayden S Shosh 2004 Signaling to NF-kappaB Genes Dev 18 2195 2224 1:CAS:528:DC%2BD2cXnslCntbY%3D 15371334
73. S Balakrishnan J Mathew CS Paulose 2010 Cholinergic and glutamergic receptor functional regulation in long-term, low dose somatotropin and insulin treatment to ageing rats: rejuvenation of brain function Mol Cell Endocrinol 314 23 30 1:CAS:528:DC%2BD1MXhtlWhtr3F 19666081
74. JM Conner KM Franks AK Titterness K Russell DA Merrill BR Christie TJ Sejnowski MH Tuszynski 2009 NGF is essential for hippocampal plasticity and learning J Neurosci 35 10883 10889
75. Brunton S (2009) Beyond glycemic control: treating the entire type 2 diabetes disorder. Postgrad Med. doi: 10.3810/pgm.2009.09.2054
76. Y Li KB Duffy MA Ottinger B Ray JA Bailey HW Holloway D Tweedie T Perry MP Mattson D Kapogiannis K Sambamurti DK Lahiri NH Greig 2010 GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease J Alzheimers Dis 19 1205 1219 1:CAS:528:DC%2BC3cXjslamtr0%3D 20308787
77. EE Tuppo HR Arias 2005 The role of inflammation in Alzheimer's disease Int J Biochem Cell Biol 37 289 305 1:CAS:528:DC%2BD2cXotlCntbw%3D 15474976
78. GJ Chen J Xu SA Lahousse NL Caggiano SM de la Monte 2003 Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection J Alzheimers Dis 5 209 228 12897406
79. W Farris S Mansourian Y Chang L Lindsley EA Eckman MP Frosch CB Eckman RE Tanzi DJ Selkoe S Guenette 2003 Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proc Natl Acad Sci USA 100 4162 4167 1:CAS:528:DC%2BD3sXivFWjsrk%3D 12634421
80. K Simons D Toomre 2000 Lipid rafts and signal transduction Nat Rev Mol Cell Biol 1 31 39 1:CAS:528:DC%2BD3MXivVGjtbo%3D 11413487
81. R Ehehalt P Keller C Haass C Thiele K Simons 2003 Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts J Cell Biol 160 113 123 1:CAS:528:DC%2BD3sXjslWmsw%3D%3D 12515826
82. JM Cordy NM Hooper AJ Turner 2006 The involvement of lipid rafts in Alzheimer's disease Mol Membr Biol 23 111 122 1:CAS:528:DC%2BD28Xis1Citb8%3D 16611586
83. S Wahrle P Das AC Nyborg C McLendon M Shoji T Kawarabayashi LH Younkin SG Younkin TE Golde 2002 Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains Neurobiol Dis 9 11 23 1:CAS:528:DC%2BD38Xht1GnsLc%3D 11848681
84. JM Cordy I Hussain C Dingwall NM Hooper AJ Turner 2003 Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein Proc Natl Acad Sci USA 100 11735 11740 1:CAS:528:DC%2BD3sXotFKmtbY%3D 14504402
85. Sima AAF, Zhang W (2010) Caveolin 1 plays a central role in amyloidogenesis in type 2 diabetes (abstract). XXth Neurodiab, EASD Stockholm
86. DJ Selkoe 2001 Alzheimer's disease genes, proteins and therapy Physiol Rev 81 741 766 1:CAS:528:DC%2BD3MXislCrsLc%3D 11274343
87. A Papassotiropoulos MA Wollmer M Tsolaki F Brunner D Molyva D Lütjohann RM Nitsch C Hock 2005 A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease J Clin Psychiatry 66 940 947 1:CAS:528:DC%2BD2MXpsVeqtLc%3D 16013913
88. DM Holtzman KR Bales T Tenkova AM Fagan M Parsadanian LJ Sartorius B Mackey J Olney D McKeel D Wozniak SM Paul 2002 Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease Proc Natl Acad Sci USA 97 2892 2897
89. SS Petanceska S Gandy 1999 The phosphatidylinositol 3-kinase inhibitor wortmannin alters the metabolism of the Alzheimer's amyloid precursor protein J Neurochem 73 2316 2320 1:CAS:528:DyaK1MXns1ehtbk%3D 10582589
90. LM Refolo B Malester J LaFrancois T Bryant-Thomas R Wang GS Tint K Sambamurti K Duff MA Pappolla 2000 Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model Neurobiol Dis 7 321 331 1:CAS:528:DC%2BD3cXmtVGntb8%3D 10964604
91. M Simons P Keller B De Strooper K Beyreuther CG Dotti K Simons 1998 Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons Proc Natl Acad Sci USA 95 6460 6464 1:CAS:528:DyaK1cXjtlKgt7o%3D 9600988
92. H Jurevics P Morell 1995 Cholesterol for synthesis of myelin is made locally, not imported into brain J Neurochem 64 895 901 1:CAS:528: DyaK2MXjt1ShsLw%3D 7830084
93. F de Pablo EJ de la Rosa 1995 The developing CNS: a scenario for the action of proinsulin, insulin and insulin-like growth factors Trends Neurosci 18 143 150 7754526
94. AAF Sima H Kamiya 2008 Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes? Curr Drug Targets 9 37 46 1:CAS:528:DC%2BD1cXisFSnsbo%3D 18220711
95. AAF Sima Z-G Li 2005 The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetes Diabetes 54 1497 1505 1:CAS:528:DC%2BD2MXktVCksbo%3D 15855338
96. T Uetsuki K Takemoto I Nishimura M Okamoto M Niinobe T Momoi M Miura K Yoshikawa 1999 Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein J Neurosci 19 6955 6964 1:CAS:528:DyaK1MXlt1Chsbg%3D 10436052
97. T Matsui K Ramasamy M Ingelsson H Fukumoto C Conrad MP Frosch MC Irizarry J Yuan BT Hyman 2006 Coordinated expression of caspase 8, 3 and 7 mRNA in temporal cortex of Alzheimer disease: relationship to formic acid extractable abeta42 levels J Neuropathol Exp Neurol 65 508 516 1:CAS:528: DC%2BD28XmtlKhtbc%3D 16772874
98. Anonymous Author 2010 Acetyl-l-carnitine monograph Altern Med Rev 15 76 83
99. SA Zanelli NJ Solenski RE Rosenthal G Fiskum 2005 Mechanisms of ischemic neuroprotection by acetyl-l-carnitine Ann NY Acad Sci 1053 153 161 1:CAS:528:DC%2BD28XotlKksQ%3D%3D 16179519
100. Sima AAF (2009) Pathobiology of diabetic encephalopathy in animal models. In: Biessels GJ, Luchsinger JA (eds) Diabetes and the brain. Humana Press, Clifton, pp 409-431
101. B Kim C Backus SS Oh JM Hayes EL Feldman 2009 Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes Endocrinology 150 5294 5301 1:CAS:528:DC%2BD1MXhsFGqtb%2FF 19819959
102. C Ryan A Vega A Drash 1985 Cognitive deficits in adolescents who developed diabetes early in life Pediatrics 75 921 927 1:STN:280: DyaL2M7ovFKntw%3D%3D 3991281
103. EA Northam PJ Anderson R Jacobs M Hughes GL Warne GA Werther 2001 Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset Diabetes Care 24 1541 1546 1:STN:280:DC%2BD3MvnvV2nuw%3D%3D 11522696
104. EA Northam D Rankins A Lin RM Wellard GS Pell SJ Finch GA Werther FJ Cameron 2009 Central nervous system function in youth with type 1 diabetes 12 years after disease onset Diabetes Care 32 445 450 19151204
105. CM Ryan 2006 Why is cognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis Pediatr Diabetes 7 289 297 17054452
106. MA Fox RS Chen CS Holmes 2003 Gender differences in memory and learning in children with insulin-dependent diabetes mellitus (IDDM) over a 4-year follow-up interval J Pediatr Psychol 28 569 578 14602847
107. EJ Austin IJ Deary 1999 Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the diabetes control and complications trial data Diabetes Care 22 1273 1277 1:STN:280: DyaK1MvgvVKntQ%3D%3D 10480770
108. S Ehehalt G Blumenstock AM Willasch R Hub MB Ranke A Neu DIARY-Study Group Baden-Württemberg 2008 Continuous rise in incidence of childhood type 1 diabetes in Germany Diabet Med 25 755 757 1:STN:280:DC%2BD1czns1ertw%3D%3D 18544113
109. V Harjutsalo L Sjöberg J Tuomilehto 2008 Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study Lancet 371 1777 1782 18502302
110. P Kumar P Krishna SC Reddy M Gurappa SR Aravind C Munichoodappa 2008 Incidence of type 1 diabetes mellitus and associated complications among children and young adults: results from Karnataka Diabetes Registry 1995-2008 J Ind Med Assoc 106 708 711
111. EURODIAB ACE Study Group 2000 Variation and trends in incidence of childhood diabetes in Europe Lancet 355 873 876
112. MS Ho NJ Weller FJ Ives CL Carne K Murray RI Vanden Driesen TP Nguyen PD Robins M Bulsara EA Davis TW Jones 2008 Prevalence of structural central nervous system abnormalities in early-onset type 1 diabetes mellitus J Pediatr 153 385 390 18534238
113. G Musen IK Lyoo CR Sparks K Weinger J Hwang CM Ryan DC Jimerson J Hennen PF Renshaw AM Jacobson 2006 Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry Diabetes 55 326 333 1:CAS:528: DC%2BD28XhsFajsrs%3D 16443764
114. WH Hoffman CM Artlett W Zhang CW Kreipke GG Passmore JA Rafols AAF Sima 2008 Receptor for advanced glycation end products and neuronal deficit in the fatal brain edema of diabetic ketoacidosis Brain Res 1238 154 162 1:CAS:528:DC%2BD1cXht1KntbjK 18775683
115. E van Duinkerken M Klein NS Schoonenboom RP Hoogma AC Moll FJ Snoek CJ Stam M Diamant 2009 Functional brain connectivity and neurocognitive functioning in patients with long-standing type 1 diabetes with and without microvascular complications: a magnetoencephalography study Diabetes 58 2335 2343 19584309
116. TJ Wilkins 2001 The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes Diabetologia 44 914 922
117. D Dabelea 2009 The accelerating epidemic of childhood diabetes Lancet 372 1999 2000
118. JC Chan V Malik W Jia T Kadowaki CS Yajnik KH Yoon FB Hu 2009 Diabetes in Asia: epidemiology, risk factors, and pathophysiology JAMA 301 2129 2140 1:CAS:528:DC%2BD1MXmsFaks7k%3D 19470990
119. Salem MA, Matta LF, Tantawy AA, Hussein M, Gad GI (2002) Single photon emission tomography (SPECT) study of regional cerebral blood flow in normoalbuminuric children and adolescents with type 1 diabetes. 3:155-162
120. DC Perantie J Wu JM Koller A Lim SL Warren KJ Black M Sadler NH White T Hershey 2007 Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes Diabetes Care 30 2331 2337 17575089
121. JI Malone S Hanna S Saporta RF Mervis CR Park L Chong DM Diamond 2008 Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory Pediatr Diab 9 531 539
122. GJ Biessels A Kamal GM Ramakers IJ Urban BM Spruijt DW Erkelens WH Gispen 1996 Place learning and hippocampal synaptic plasticity in streptozotocin- induced diabetic rats Diabetes 45 1259 1266 1:CAS:528:DyaK28XlsFemtLk%3D 8772732
123. GJ Biessels A Kamal IJ Urban BM Spruijt DW Erkelens WH Gispen 1998 Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment Brain Res 800 125 135 1:CAS:528: DyaK1cXksVyqs74%3D 9685609
124. AAF Sima S Yagihashi 1986 Central-peripheral distal axonopathy in the spontaneously diabetic BB- rat: Ultrastructural and morphometric findings Diab Res Clin Pract 1 289 298 1:STN:280:DyaL283ks12msA%3D%3D
125. M Kamijo PV Cherian AAF Sima 1993 The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat Diabetologia 36 893 898 1:CAS:528:DyaK2cXhvVakurg%3D 8243866
126. Biessels GJ (2007) Diabetic encephalopathy. In: Veves A, Malik RA (eds) Diabetic neuropathy-clinical management. Humana Press, Totowa, p 18
127. WE Crusio H Schwegler 2005 Learning spatial orientation tasks in the radial-maze and structural variation in the hippocampus in inbred mice Behav Brain Funct 1 1 3
128. SI Wiener CA Paul H Eichenbaum 1989 Spatial and behavioral correlates to hippocampal neuronal activity J Neurosci 9 2737 2763 1:STN:280: DyaL1MzmtFKntg%3D%3D 2769364
129. JG Blanchard PM Duncan 1997 Effect of the combination of insulin, glucose and scopolamine on radial arm maze performance Pharmacol Biochem Behav 58 209 214 1:CAS:528:DyaK2sXltFCqu7g%3D 9264093
130. G Grunberger X Qiang Z-G Li ST Mathews D Sbriessa A Shisheva AAF Sima 2001 Molecular basis for the insulinomimetic effects of C-peptide Diabetologia 44 1247 1257 1:CAS:528:DC%2BD3MXnsFaksbY%3D 11692173
131. Sima AAF, Wahren J (eds) (2009) The relevance of C-peptide in diabetes and its complications. Rev Diab Stud Special Issue 6:131-224
132. C Toth AM Schmidt UI Tuor G Francis T Foniok V Brussee J Kaur SF Yan JA Martinez PA Barber A Buchan DW Zochodne 2006 Diabetes, leukoencephalopathy and RAGE Neurobiol Dis 23 445 461 1:CAS:528:DC%2BD28Xntl2ntbw%3D 16815028
133. M Winick A Noble 1965 Quantitative changes in DNA, RNA and protein during prenatal and postnatal growth in the rat Dev Biol 12 451 466 1:CAS:528:DyaF28XjvVSqtQ%3D%3D 5884354
134. W Xu C Qiu B Winblad L Fratiglioni 2007 The effect of borderline diabetes on the risk of dementia and Alzheimer's disease Diabetes 56 211 216 1:CAS:528:DC%2BD2sXhtVWltL4%3D 17192484
135. CL Leibson WA Rocca VA Hanson R Cha E Kokmen PL O'Brien PJ Palumbo 1997 Risk of dementia among persons with diabetes mellitus: a population-based cohort study Am J Epidemiol 145 301 308 1:STN:280:DyaK2s7ovVKkuw%3D%3D 9054233 (Pubitemid 27082028)
136. S Wild G Roglic A Green R Sicree H King 2004 Global prevalence of diabetes Diabetes Care 27 1047 1053 15111519
137. International Diabetes Federation (2000) Diabetes Atlas 2000. International Diabetes Federation, Brussels
138. CP Ferri M Prince C Brayne H Brodaty L Fratiglioni M Ganguli K Hall K Hasegawa H Hendrie Y Huang A Jorm C Mathers PR Menezes E Rimmer M Scazufca Alzheimer's Disease International 2005 Global prevalence of dementia: a Delphi consensus study Lancet 366 2112 2117 16360788